Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.04 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |